Detalhe da pesquisa
1.
Evaluation of the endothelin receptor antagonists ambrisentan, darusentan, bosentan, and sitaxsentan as substrates and inhibitors of hepatobiliary transporters in sandwich-cultured human hepatocytes.
Can J Physiol Pharmacol
; 88(6): 682-91, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20628435
2.
Darusentan is a potent inhibitor of endothelin signaling and function in both large and small arteries.
Can J Physiol Pharmacol
; 88(8): 840-9, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20725142
3.
Intravenous Infusion of the Novel HNO Donor BMS-986231 Is Associated With Beneficial Inotropic, Lusitropic, and Vasodilatory Properties in 2 Canine Models of Heart Failure.
JACC Basic Transl Sci
; 3(5): 625-638, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-30456334
4.
CXL-1020, a Novel Nitroxyl (HNO) Prodrug, Is More Effective than Milrinone in Models of Diastolic Dysfunction-A Cardiovascular Therapeutic: An Efficacy and Safety Study in the Rat.
Front Physiol
; 8: 894, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29209225
5.
Resuscitation with a novel hemoglobin-based oxygen carrier in a Swine model of uncontrolled perioperative hemorrhage.
J Trauma
; 54(5): 915-24, 2003 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-12777904